Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Mckesson Corp MCK

Healthcare
McKesson Corporation is a provider of diversified healthcare services. The Company is engaged in advancing health outcomes for patients everywhere. Its U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over the counter (OTC) pharmaceutical drugs and other healthcare-related products in the United States. Its Prescription Technology Solutions segment helps... see more

Recent & Breaking News (NYSE:MCK)

McKesson's Board of Directors Elects James H. Hinton and Kathleen Wilson-Thompson as New Directors

Business Wire January 18, 2022

McKesson Corporation Announces Third Quarter Fiscal 2022 Earnings Release Date and Participation in January Conference

Business Wire December 29, 2021

McKesson Corporation Enters Agreement to Sell its Austrian Business to Quadrifolia Management GmbH

Business Wire December 20, 2021

McKesson Investor Day to Highlight Progress Against Growth Strategies and Long-Term Financial Targets

Business Wire December 8, 2021

McKesson to Host Investor Day on December 8, 2021

Business Wire December 1, 2021

McKesson Reports Fiscal 2022 Second-Quarter Results

Business Wire November 1, 2021

McKesson Corporation Enters Agreement to Sell UK Businesses to AURELIUS

Business Wire November 1, 2021

McKesson Declares Quarterly Dividend

Business Wire October 28, 2021

Distributors Announce Settlement With Cherokee Nation

Business Wire September 28, 2021

McKesson Corporation to Announce Second Quarter Fiscal 2022 Results on November 1, 2021

Business Wire September 27, 2021

Mckesson's Board of Directors Elects Dr. Richard H. Carmona as New Independent Director

Business Wire September 7, 2021

McKesson to Host Investor Day on December 8, 2021

Business Wire August 16, 2021

McKesson Reports Fiscal 2022 First-Quarter Results

Business Wire August 4, 2021

McKesson Raises Quarterly Dividend by 12% to $0.47 Per Share

Business Wire July 26, 2021

McKesson Corporation Announces Pricing and Upsizing of Tender Offer

Business Wire July 22, 2021

McKesson Corporation Announces Early Tender Results and Intention to Increase the Tender Cap

Business Wire July 22, 2021

Distributors Announce Proposed Opioid Settlement Agreement

Business Wire July 21, 2021

Distributors Reach Opioid Settlement Agreement With New York State

Business Wire July 20, 2021

McKesson Corporation Announces Offer to Purchase up to $500 Million Aggregate Principal Amount of Debt

Business Wire July 8, 2021

McKesson Corporation Enters Agreement to Sell Certain European Businesses to the PHOENIX Group

Business Wire July 7, 2021